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Coated vesicles playa critical role in the process of melano-
genesis. Antisera raised against a coated vesicle fraction from 
mouse melanoma cells recognize two major glycoprotein 
antigens, band 1(47-55 kd) and band II (90-120 kd). We 
demonstrate that band II is lysosome-associated membrane 
protein 1 (LAMP-1) by the following criter~a: 1) the m~lecu­
lar weight and abundance of LAMP-l vanes among tIssues 
but is always identical to that of band II; 2) band II and 
C oated vesicles were first implicated in the process of melanosomal biogenesis by studies employing the electron microscope [1-3]. From these studies, a model was developed in which vesicles containing tyrosinase arise from the Golgi apparatus and fuse 
with stage II melanoso~es, thereby initiating the pro~ess of me~ano­
genesis (see [4] for revlew). Subsequently, by adaptmg techruques 
developed for the isolation of coated vesicles from brain, highly 
purified coated vesicle fractions were prepared from murine and 
hamster melanoma cells and shown to contain high levels of tyro-
sinase, dopachrome tautomerase (formerly called dopachrome con-
version factor), and gammaglutamyl transferase, three enzymes 
implicated in mela~oger:esis [5,~]. Dihydroxyindole a~d dihydrox-
yindole-2-carboxyhc aCld, two lmportant melanogeruc precursors, 
are also present in the vesicular fraction [7]. 
We have recently shown [8] that rabbit antisera generated to a 
highly purified vesicle fraction from Cloudman S91 mouse mela-
noma cells recognize two major glycoprotein antigens: Band I (47 -
55 kd) and band II (90 -120 kd). Although both of these integral 
membrane proteins are present in the vesicular fraction of mouse 
melanoma cells and normal mouse melanocytes, only band I is spe-
cific to melanocytes [8]' In contrast, band II is present in all tissues 
examined, including brain, kidney, liver, and lung. 
LAMP-1 (lysosome-associated membrane protein 1) is one of 
three major glycoproteins of the lysosomal membrane [9]. Like 
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Abbreviations: 
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SDS-PAGE: Sodium dodecylsulfate-polyacrylarnide gel electro-
phoresis 
TBS: Tris-buffered saline 
LAMP-1 co-migrate in sucrose gradient sedimentation stud-
ies; 3) immunodepletion of cell extracts with antivesicle 
serum removes all LAMP-1; and 4) intact organelles immun-
oisolated with antivesicle serum contain band II and LAMP-
l. Our results further confirm the long-suspected relation-
ship between melanosomes and the lysosomal lineage of 
organelles.] Invest Dermatol1 00:11 0-114, 1993 
band II, it migrates broadly on sodium dodecylsulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) with an apparent Mr of 
90-120 kd [9] . Due to the similarity in their molecular weights and 
the fact that a number of mutations, such as the beige mutation in 
mice [10] and Chediak-Higashi syndrome in humans [11], affect 
both melanosomes as well as lysosomes and lysosomally derived 
organelles [10] , we sought to determine whether band II and 
LAMP-1 were related. 
Our results, using a combined immunologic, biochemical, and 
cellular approach, demonstrate that LAMP-1 is the melanocyte ve-
sicular membrane glycoprotein band II, and thereby confirm a 
long-suspected relationship between melanosomes and the lysoso-
mal lineage of organelles. 
METHODS 
Cell Culture Cloudman S91 cells were cultured as previously 
reported [12]; Melan-a cells were obtained from D. Bennett via V. 
Hearing (NCI) and cultured as described [13]. 
Immunologic Reagents and Techniques The preparation and 
characterization of rabbit antiserum to a purified vesicular fraction 
from Cloudman S91 cells was described previously [8]. Rat mono-
clonal antibodies directed against murine LAMP-l (1D4B) and 
another directed against murine LAMP-2 (ABL-93) [14] were pur-
chased from the Developmental Studies Hybridoma Bank (Univer-
sity ofIowa and Johns Hopkins University). Rabbit anti-rat immu-
noglobulin antibodies were purchased from Sigma Chemical Co. 
(St. Louis, MO). 
Metabolic labeling with [35S] methionine, immunoprecipitation, 
SDS-PAGE and immunoblotting were all performed as described 
previously [8,15]. Brain, kidney, and liver from adult C57BL/6J 
mice and Cloud man S91 cells were homogenized and extracted as 
described [8] . 
Immunoisolation using protein A - coated magnetic beads was an 
adaptation [8,16] of a method developed for the immunoisolation of 
secretory vesicles from neuronal and endocrine cells [17] . 
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Figure 1. Immunolocalization of antigens recognized by antivesicle 
serum. C10udman 591 cells were permeabilized and immunofluorescence 
performed with antivesicle serum (A) or pre-immune serum (B) as de-
scribed in Materials alld Methods. Note the intense granular pattern evident 
in A . Bar, 4 microns. 
For immunofluorescence microscopy, Cloudman S91 cells were 
cultured on cover slips for 48 h, rinsed in phosphate-buffered saline 
(PBS), and fixed for 30 min in PBS containing 3% paraformalde-
hyde and 0.02% glutaraldehyde, followed by three rinses in PBS. 
Cells were permeabilized in acetone at - 20 ° C for 15 seconds, 
rinsed in PBS, exposed to antivesicle serum for 1 h at 37°C, and 
rinsed five times in PBS prior to exposure to Texas-red-labeled 
anti-rabbit immunoglobulin antibody (Amersham, Arlington 
Heights, IL) for 1 h at 37°C. Unbound antibody was removed by 
washing the cells nve times in PBS. Specificity and background 
were checked by labeling parallel cultures with only T exas Red -
labeled immunoglobulin. 
For immunoelectron microscopy, Cloudman S91 cells were 
seeded into Lab Tek chamber slides (Nunc, Inc. , N aperville, IL) , 
and subsequentl y embedded as follows [18]: cells were washed twice 
in PBS, fixed with 4% paraformaldehyde, 1 % glutara ldehyde, and 
0.2% picric acid in 0.1 M phosphate buffer containing 0.5 mM 
calcium chloride (pH 7.4) for 20 min at room temperature, washed 
three times, and incubated in 0.25% tannic acid for 10 min at room 
temperature. Cells were washed three times, quenched in 50 mM 
ammonium chloride for 20 min at DoC, washed four times in 0.1 M 
maleate buffer (pH 6.5), treated with 2% uranyl acetate (pH 4.0) for 
30 min at O°C, dehydrated with acetone, and infiltrated with Lowi-
cryl K4M at -20 °C and the embedding medium polymerized 
under ultraviolet irradiation at -20°C for 2 d. 
Embedded cells were mounted and sectioned, and sections placed 
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Figure 2. Immunoelectronmicroscopy using antivesicle serum. C1oud-
man 591 melanoma cells (a) untreated or (b and c) treated with M5H and 
isobutylmethylxanthine and immunostained with antivesicle serum at (a) 
1 : 10,000 to dramatically. reduce nonspecific background staining or (b 
and c) 1: 100. Gold parhcles predominate on stage I - II melanosomes 
(arrowheads and arrow m lfIset to a), and on large, electron lucent vacuoles 
(asterISks) that resemble late endosomes. We have previously demon-
strated that these latter organelles are LAMP-1 positive and represent 
putative melanosome precursors [16]. 5tage III -IV melanosomes (opell 
arrolV~) have far fewe~ gold particles than do the other organelles. (G, 
GolgJ apparatus; M, nutochondria; N, nucleus.) Bars, a, 0.54 microns; illset 
to a, 0.16 nucrons; band c, 0.60 microns. 
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Table I. Density of Gold Labeling on Organelles Immunocytochemically Stained with Antivesicle Serum· 
Number of Gold Particles/Micron2 
Cells Antiserum (dilution) Stage I-II Melanosomes State III-IV Melanosomes Mitochondcia 
Amelanotic 
Amelanotic 
Melanotic 
Melanotic 
Melanotic 
av (1:100) 
av (1 :200) 
av (1:100) 
av (1 :200) 
Preimmune (1:200) 
153.9 ± 14.1 
75.7 ± 3.9 
100.8 ± 5.7 
84.9 ± 4.2 
10.0 ± 2.9 
61.5 ± 5.4 
59.8 ± 4.5 
10.0 ± 2.0 
10.4 ± 1.1 
8.3 ± 1.0 
14.4 ± 1.9 
15.1 ± 2.2 
9.0 ± 2.2 
• The subcellular distribution of the antigens recognized by the antivesicle serum in Cloudman 591 cells was analyzed by immunoelectronmicroscopy and the density of gold 
labeling quantified as detailed in Materia ls arid Methods. 
on nickel grids and processed for .im~unola~el.ing as follows: sp.eci-
mens were washed with 50 mM Tns contammg 150 mM sodIUm 
chloride at pH 7.4 (TBS), blocked with 1 % bovine serum albumin 
in TBS containing 0.02% Tween 20 (TBS-ICC) for 10 min, treated 
with the primary antisera diluted in TBS-ICC for 2 h at room 
temperature and ~ub~equently w~shed extensiv~ly. Primary antisera 
consisted of antlveslcle or pre-Immune rabbit serum (at 1: 100, 
1: 200, or 1: 10,000). Washed specimens were incubated with pro-
tein A conjugated to 5-nm-diameter colloidal gold particles (di-
luted 1: 10 in TBS) for 1 h at room temperature, washed exten-
sively, stabilized with 2% glutaraldehyde for 5 min, and stained 
sequentially with 2~o osmi~m tetroxide for 15 min and. Reynold's 
lead citrate for 3 mm. Speclmens were then washed, dned, coated 
with Formvar, viewed, and photographed in a JEOL JEM-l 00 CX 
transmission electron microscope. 
Coded grids were viewed and the perinuclear area from 20 - 30 
randomly selected cells per sample group were photographed at 
20,000 times and subsequently printed to 50,000 times. Each mi-
crograph contained on average 15 melanosomes. Prints were 
mounted on a 45-position menufield digitizing tablet of a Zeiss 
interactive digital analysis system. The perimeter and number of 
gold particles within each melanosome and mitochondria was 
traced and counted using a pen cursor. By computer, the number of 
gold particles per square micron of organelle was determined and 
means calculated prior to breaking the code. 
RESULTS 
Antivesicle Serum Recognizes Stage I and II Melanosomes 
Immunofluorescent analysis utilizing antivesicle serum and perme-
abilized Cloudman S91 melanoma cells revealed that the antibody 
recognized intracellular granules distributed throughout the cyto-
plasm and grouped in the perinuclear area (Fig lA). No specific 
labeling was seen with pre-immune serum (Fig IB) . When the 
antivesicle serum was used for immunoelectronmicroscopy, gold 
particles we~e localiz.ed to spherical o~ "gourd': shaped vacuoles, 
many of which contamed poorly orgamzed matnx material (stage I 
melanosomes) or well-arranged matrix filaments (stage II melano-
somes) (Fig 2) . The normally amelanotic Cloud man cells can be 
induced to melanize by combined treatment with MSH and isobu-
tylmethylxanthine, which we have previously shown to result in 
the induction of stage III and IV melanosomes [1 9]. When cells 
treated in this fashion for 48 h were analyzed with the antivesicle 
serum, some labeling of stage III - IV melanosomes could be noted, 
but the predominant structures label~d were still stage I and II mela-
nosomes (Fig 2B,C). These observations were further confirmed by 
quantification of the number of gold particles per square micron 
(Table I) . 
We have recently shown [16] that in highly melanized cells, stage 
I and, to a lesser extent, stage II melanosomes, contain both tyrosin-
ase-related protein- l and LAMP-I, a major lysosomal membrane 
glycoprotein, whereas these proteins are absent or present in very 
low quantities in the tyrosinase-rich stage III and stage IV melano-
somes. Because the antigen(s) recognized by the antivesicle serum 
are also present for the most part in stage I -II melanosomes, and 
because band II, one of the two antigens recognized by the antivesi-
cle serum, has a molecular weight of 90 - 120 k [8], similar to that 
reported for LAMP-l [9] , we sought to determine whether band II 
could be identical to LAMP-I. 
Antivesicle Serum Recognizes an Antigen of the Same Mo-
lecular Weight as LAMP-1 When equal quantities of protein 
from extracts of Cloudman S91 melanoma cells as well as from 
brain, kidney, and liver from C57BL6/J mice were subjected to 
SDS-PAGE and analyzed by Western immunoblotting, both the 
antivesicle serum and a monoclonal antibody to mouse LAMP-l 
recognized a broadly migrating band ofMr 90-120 kd (Fig 3). The 
Mr and abundance of this protein varied from tissue to tissue, but the 
results obtained with both antibodies were always similar (Fig 
3A,B). In contrast, a monoclonal antibody to mouse LAMP-2 recog-
nized a band whose abundance and molecular weight could be read-
ily differentiated from that of band II (Fig 3); unlike band II and 
LAMP-l, for example, LAMP-2 is present in very low quantities in 
brain (Fig 3). 
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Figure 3. Western blotting analysis. Twenty micrograms of extracts of 
brain (B), kidney (K), and liver (L) from C57BL/6J mice, and of cultured 
Cloudman 591 melanoma cells (591), were subjected to 5D5-PAGE anal-
ysis and then immunoblotted with rabbit anti vesicle serum (a vesicle), a 
rat monoclonal against murine LAMP-l (aLAMP-l) and against murine 
LAMP-2 (aLAMP-2). The migration of molecular weight markers is 
shown at left. Note that the Mr of the 90-120-kd band recogrtized by the 
antivesicle serum matches that of LAMP-I, but is different from that of 
LAMP-2 (best seen in B lanes). The antivesicle serum also recogrlized a 
broadly migrating band of Mr 45 - 60 kd (band I) that is not recognized by 
the two anti-LAMP antibodies. 
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Figure 4. Sucrose density sedimentation analysis of band II/LAMP-I. A 
detergent-solubilized extract of melanoma cells was subjected to sedimen-
tation in a 10-40% sucrose gradient as described in Methods. Fractions 
were collected from the top of the gradient, and equal quantities of each 
fraction were subjected to SDS-PAGE and immunoblotting with anti-
vesicle serum (A) and anti LAMP-1 (B) . Note that the Mr 90-120-kd 
antigen recognized by both antibodies migrates with a peak at fraction 
3-5, and a smaller peak in fraction 10. 
LAMP-1 and Band II Co-Sediment on Sucrose Gradients 
To determine if the native size/molecular weight of LAMP-1 and 
band II were similar, detergent-solubized extracts of immortalized 
cultured mouse melanocytes (mel an-a cells [13]) were centrifuged 
through sucrose density gradients and the collected fractions were 
subjected to Western immunoblotting analysis with anti vesicle 
serum and aLAMP-1. The results in Fig 4 demonstrate that under 
these non-denaturing conditions, the sedimentation of band II and 
LAMP-1 are identical. 
Antivesicle Serum Can Immunodeplete LAMP-1 aLAMP-1 
precipitates a Mr 90-120 kd antigen from extracts of Cloudman 
591 cells metabolically labeled with 35S methionine (Fig 5). We 
have previously shown [8] that, from these same cells, anti vesicle 
serum immunoprecipitates two antigens of Mr 47- 55 kd (band I) 
and 90 - 120 kd (band II). When extracts of metabolically labeled 
cells were first subjected to immunoprecipitation with antivesicle 
serum and subsequently with aLAMP-1, anti vesicle serum quantita-
tively removed all LAMP-1 reactivity from the extracts (Fig 5). 
Preprecipitation with control rabbit serum had no effect on the 
amount ofLAMP-! subsequently precipitated. As a positive control, 
preprecipitation with aLAMP-1 was performed. As expected, it 
removed all LAMP-! from the extracts. 
Antivesicle Serum Immunoisolates Organelles Containing 
LAMP-1 When magnetic beads coated with antivesicle serum 
were used to immunoisolate intact organelles from postnuclear su-
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Figure 5. Immunoprecipitation analysis. Extracts of CIoudman 591 cells 
met~boJically labeled with V5S) methionine were pre-cleared with normal 
rabbit serum (latle A), antiveslcle serum (latte B), or a monoclonal anti-
body to LAMP-1 (lane C), followed by immunoprecipitation with anti-
bod~ to LAMP-I. In latle A ,. a Mr.90 -120-kd band is specifically immuno-
preapltated, but pre-cleanng With the antibodies to vesicles or LAMP-l 
quantitatively removes all immunoreactive material from the extract. 
pernatants of cultured melan-a cells, and the immunoisolated or-
ganelles su~jec~ed to W ester~ immunoblotting, the isolated organ-
elles were nch 111 LAMP-1 (Fig 6). In contrast, if beads coated with 
contr?1 serum were used, no LAMP-1 was isolated. (The reverse 
expenment co~l~ not be performed because the epitope recognized 
by aLAMP-1Is lJ1tralununal, and thus inaccessible in intact organ-
elles.) 
DISCUSSION 
A relationship between lysosomes and melanosomes has long been 
suspected. Lysosomal enzymes are ~ransported from the trans-Golgi 
ne~ork to Iysoso~nal precursors via a subset of coated vesicles [20]. 
A~ld phosphatase IS a well-described marker for lysosomes and cer-
talJ1 other trans Goigi network-derived secretory organelles; its pres-
ence I~as been ~emonstrated 111 melanosomes by both biochemical 
and hlstochemlCal means [21-23] . At least 10 different recessive 
mutations in the laboratory mouse affect coat color ocular pigmen-
tation, and the secretion oflysosomal hydrolases or 'lysosomal struc-
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Figure 6. Immunoisolation of organelles with antivesicle serum. Post-
nuclear supernatants of melan-a cells we~e subjected to immunoisolation 
as described [8,16] using beads coated WIth antiveslcle serum (A,C,D,F) 
or pre-immune serum.(B,E) . Following SDS-PAGE, immunoblotting was 
performed with antibody to LAMP-1 (lalle A), antivesicle serum (Jall es B 
and C ), a control rat monoclonal antibody (lalle D), and pre-immune 
rabbit serum (Jan es E and F). Note that beads coated with antivesicle 
serum immunoisolated organelles coating both LAMP-1 and band n (lall es 
A and C), whereas neither antigen was brought down by beads coated 
with pre-immune serum (lane B) or when immunoblotting was performed 
with control antibodies (D-F) . 
ture [10,24]. Furthermore, ~istochemical evidence suggests that the 
interior of melanosomes, like that of endosom es and lysosomes, 
becomes acidified [25]. 
Our results demonstrate that one of the major lysosomal mem-
brane glycoproteins, LAMP-I, is band II, present in subcellular 
organell es implicated in mel anosomal biogenesis. W e have recently 
reported that thc::re is an early melanosomal compartment~ perinu-
clear in distribution, that IS n ch 111 both LAMP-l and tyros1l1ase-re-
lated protein-l, the product of the murine brown locus. These data 
show that there may be proteins shared by both organelles of the 
lysosomal lineage and melanosomes. Whether this is because mel a-
nosomes and lysosom es share a common biogenetic pathway up to a 
point and then diverge, o~ because the melanosome represents a 
"specialized" lysosome umque to the melanocyte , rema1l1s to be 
determined. 
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